期刊文献+

Her-2过表达型乳腺癌磁共振-扩散加权成像及动态增强成像分析 被引量:11

Diffusion Weighted Imaging and Dynamic Contrast-Enhanced MR Imaging Features of Her-2 Over Expression Subtype of Breast Cancer
下载PDF
导出
摘要 目的探讨Her-2过表达型乳腺癌磁共振-扩散加权成像(MR-DWI)及动态增强成像表现。方法收集我院经病理学证实的18例Her-2过表达型乳腺癌及36例非Her-2过表达型乳腺癌病例。术前均进行3.0T高场MR-DWI及动态增强扫描,记录并分析病灶MR表现。结果 18例Her-2过表达型乳腺癌中,61.1%(11/18)表现为边缘毛刺征;55.6%(10/18)增强后表现不均匀强化;44.4%(8/18)伴有腋窝淋巴结转移,并且与非Her-2过表现组之间差异有统计学意义(P<0.05)。b值为400、800、1000 s/mm^2,Her-2过表达型乳腺癌病灶的平均表观扩散系数(Apparent Diffusion Cofficent,ADC)值分别为(1.498±0.23)×10^(-3)、(1.317±0.21)×10^(-3)、(1.232±0.19)×10^(-3) mm^2/s,非Her-2过表达组乳腺癌病灶的平均ADC值分别为(1.234±0.28)×10^(-3)、(1.053±0.25)×10^(-3)、(0.944±0.21)×10-3 mm^2/s。并且在b为800 s/mm^2时,与非Her-2过表达组之间的差异具有统计学意义(P<0.05)。结论 MRI边缘毛刺征、不均匀强化、相对较高的ADC值对Her-2过表达型乳腺癌的诊断有参考意义,且Her-2过表达型乳腺癌更易发生腋窝淋巴结转移。 Objective To investigate the dynamic contrast-enhanced MR imaging(DCE-MRI) and diffusion-weighted imaging(DWI) features of Her-2 over expression subtype of breast cancers.Methods Altogether 18 cases of Her-2 over expression subtype of breast cancers and 36 cases of breast cancer without Her-2 over expression confirmed pathologically in the hospital were collected. All the cases were examined by using 3.0T DCE-MRI and DWI. The DCE-MRI and DWI features of Her-2 over expression subtype of breast cancer were recorded and analyzed. Results Among 18 cases of Her-2 over expression subtype of breast cancer, the speculated margin signs took up 61.1%(11/18); postenhanced heterogeneous enhancement signs accounted for 55.6%(10/18); there were 44.4%(8/18) lesions with lymph node metastasis. Statistically significant differences were seen between the margin, the way of enhancement and lymph node metastasis of the Her-2 over expression breast cancer and the breast cancer without Her-2 over expression(P0.05). When the b value was 400, 800 and 1000 s/mm^2, the ADC value of the Her-2 over expression subtype breast cancers were(1.498±0.23) ×10^(-3),(1.317±0.21)×10-3,(1.232±0.19)×10^(-3) mm^2/s, and the ADC value of the breast cancers without Her-2 over expression were(1.234±0.28)×10^(-3),(1.053±0.25)×10-3,(0.944±0.21)×10^(-3) mm^2/s. When the b value was 800 s/mm^2, there was statistically significant difference between the Her-2 over expression type breast cancers and the breast cancer without Her-2 over expression(P〈0.05). Conclusion DCE-MRI features such as the speculated margin signs, heterogeneous enhancement and the ADC values were useful for the diagnosis of Her-2 over expression subtype breast cancer. The lymph node metastases were more frequently found in Her-2 over expression subtype breast cancer.
出处 《中国医疗设备》 2016年第10期51-54,61,共5页 China Medical Devices
关键词 乳腺癌 扩散加权成像 磁共振动态增强 表观扩散系数 breast cancer diffusion weighted imaging dynamic contrast-enhanced magnetic resonance imaging apparent diffusion coefficient
  • 相关文献

参考文献14

  • 1Kim SH,Cha ES,Kim HS,et al.Diffusion-weighted imaging of breast cancer:correlation of the apparent diffusion coefficient value with prognostic factors[J] .Magn Reson Imaging,2009,30(3):615 -620.
  • 2章乐虹,彭艳华,查中青,胡以则.乳腺癌分子分型与远处转移时间及部位的分析[J].中华临床医师杂志(电子版),2012,6(11):53-55. 被引量:11
  • 3Montagna E,Bagnardi V, Rotmensz N,et al.Immunohistochemi- cally defined subtypes and outcome in occult breast carcinoma with axillary presentation[J].Breast Cancer Res Treat,2011,129(3): 867-875.
  • 4樊英,关印,赵卫红,李青,徐兵河.激素受体双阴性HER-2过表达乳腺癌的临床病理特征及预后分析[J].中华肿瘤杂志,2008,30(12):917-920. 被引量:8
  • 5王强,胡国栋.乳腺病变的MRI诊断及鉴别诊断价值[J].实用放射学杂志,2010,26(8):1181-1184. 被引量:11
  • 6Wang Y, Ikeda DM,Narasimhan B,et al.Estrogen receptor-negative invasive breast cancer: imaing features of tumors with and without human epidermal growth factor receptor type 2 overexpression[J]. Radiology,2008,246(2):367-375.
  • 7Costantini M,Belli P, Rinaldi P, et al.Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness [J]. Clin Radiol,2010,65 ( 12): 1005 - 1012.
  • 8Kul S,Cansu A,Alhan E,et al.Contribution of diffusion- weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors [J].AJR,2011,196(1):210-217.
  • 9Youk JH,Son EJ,Chung J,et al.Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes[J]. Eur Radiol,2012,22(8): 1724-1734.
  • 10柏玉涵,张东友,彭红芬,董进.MRI-DWI技术及ADC值对乳腺病变的诊断价值[J].中国医疗设备,2013,28(12):153-156. 被引量:3

二级参考文献71

  • 1陈蓉,龚水根,张伟国,陈金华,何双梧,刘宝华,李增鹏.乳腺癌MRI形态学表现与病理、分子生物学相关性研究[J].中华放射学杂志,2004,38(6):620-625. 被引量:55
  • 2邓丽萍,王林波,章士正,陈文军,章雁.乳腺动态增强核磁共振检查的临床应用价值[J].中华普通外科杂志,2005,20(3):164-166. 被引量:13
  • 3汪晓红,耿道颖,顾雅佳,彭卫军.乳腺恶性肿瘤的MRI表现及病理对照研究[J].中国医学计算机成像杂志,2005,11(2):100-106. 被引量:20
  • 4Perou CM, Sφrlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature, 2000, 406:747-752.
  • 5Abd El-Rehim DM, Ball G, Pinder SE, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterized series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysis. Int J Cancer, 2005, 116:340-350.
  • 6Ross JS, Fletcher JA. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist, 1998, 3:237-252.
  • 7Chevallier B, Heintzmann F, Mosseri V, et al. Prognostic value of estrogen and progesterone receptors in operable breast cancer:results of a univariate and multivariate analysis. Cancer, 1988, 62:2517 -2524.
  • 8Revillion F, Bonneterre J, Peyrat JP. ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer, 1998, 34:791-808.
  • 9Lal P, Tan LK, Chen B. Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas. Am J Clin Pathol, 2005, 123:541-546.
  • 10Francis G, Beadle G, Thomas S, et al. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome. Pathology, 2006,38 : 391-398.

共引文献54

同被引文献105

引证文献11

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部